← Eichor
Study identifier: NCT07733947 Synced from ClinicalTrials.gov · July 29, 2026
● Not Yet Recruiting

A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)

Condition: Subcutaneous Fat  ·  Sponsor: Caliway Biopharmaceuticals Co., Ltd.

PhasePhase 3
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

A Phase 3b, Multicenter, Two stage, Double-blind, Long term Follow up and Open-label Extension Study of Participants Who have Completed the CBL-0301 or CBL-0302 Study for Reducing Abdominal Subcutaneous Fat (Stage 1)

This description comes directly from the study's public registry record.

Talk to the study team

NT Tan  ·  +886-2-26971355  ·  CR@caliwaybiopharma.com

Always discuss trial participation with your own doctor first.

Locations (1)

Investigational site 1Encinitas, California, United States—

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07733947